Copmans; Alex Herman

Patent Applications and Registrations

Patent applications and USPTO patent grants for Copmans; Alex Herman.The latest application filed is for "salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile".

Company Profile

0.9.14

Copmans; Alex Herman - Lille BE
Copmans; Alex Herman - Beerse BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salt Of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile App 20180116964 - Stevens; Paul Theodoor Agnes ; et al.	2018-05-03
2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoro-met Hyl)benzyl)quinazolin-4(3h)-one Derivatives And Their Use As Phosphoinositide 3-kinase Inhibitors App 20170334919 - Broeckx; Rudy Laurent Maria ; et al.	2017-11-23
2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)- methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitors Grant 9,745,306 - Broeckx , et al. August 29, 2	2017-08-29
CRYSTALLINE Pl3 KINASE INHIBITORS App 20170239256 - Broeckx; Rudy Laurent Maria ; et al.	2017-08-24
Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methy- l)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxye- thyl)hex-5-ynamide Grant 9,642,799 - Broeckx , et al. May 9, 2	2017-05-09
Phosphoinositide 3-kinase inhibitors Grant 9,556,184 - Taddei , et al. January 31, 2	2017-01-31
Phosphoinositide 3-Kinase Inhibitors App 20160090389 - Taddei; David Michel Adrien ; et al.	2016-03-31
2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1 -yl)methyl)-3-(2-(trifluoromethyl)benzyl) Quinazolin-4(3h)-one Derivatives And Their Use As Phosphoinositide 3-kinase Inhibitors App 20160039826 - Broeckx; Rudy Laurent Maria ; et al.	2016-02-11
Phosphoinositide 3-kinase inhibitors Grant 9,227,977 - Taddei , et al. January 5, 2	2016-01-05
CRYSTALLINE Pl3 KINASE INHIBITORS App 20150105408 - Broeckx; Rudy Laurent Maria ; et al.	2015-04-16
Novel Pharmaceutical Formulations App 20150099768 - Broeckx; Rudy Laurent Maria ; et al.	2015-04-09
Compound App 20140274980 - Taddei; David Michel Adrien ; et al.	2014-09-18
Resolution of (.+-.)-methyl phenyl[4-[4-[[[4'(trifluoromethyl)-2-biphenylyl]carbonyl]amino]Phenyl]-1-- piperidinyl]acetate Grant 8,461,341 - Copmans , et al. June 11, 2	2013-06-11
Resolution Of (.+-.)-methyl Phenyl[4-[4-[[[4'(trifluoromethyl)-2- Biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate App 20120071660 - Copmans; Alex Herman ; et al.	2012-03-22
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile Grant 8,101,629 - Guillemont , et al. January 24, 2	2012-01-24
Salt Of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino] -2-pyrimidinyl]amino]benzonitrile App 20110150996 - Stevens; Paul Theodoor Agnes ; et al.	2011-06-23
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile Grant 7,956,063 - Guillemont , et al. June 7, 2	2011-06-07
Salt Of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile App 20110008434 - GUILLEMONT; Jerome Emile Georges ; et al.	2011-01-13
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino] benzonitrile Grant 7,638,522 - Guillemont , et al. December 29, 2	2009-12-29
Fumarate Of 4- [[4- [[4- (2-cyanoethenyl) -2,6-dimethylphenyl)amino] -2-pyrimidinyl]amino]benzonitrile App 20090215804 - Stevens; Paul Theodoor Agnes ; et al.	2009-08-27
Salt Of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile App 20090012108 - Guillemont; Jerome Emile ; et al.	2009-01-08
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile App 20060111379 - Guillemont; Jerome Emile Georges ; et al.	2006-05-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.